Trials / Conditions / Intravascular Large B-Cell Lymphoma
Intravascular Large B-Cell Lymphoma
6 registered clinical trials studyying Intravascular Large B-Cell Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma NCT06736613 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types NCT05907447 | Ruijin Hospital | — |
| Suspended | Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag NCT04799275 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Unknown | Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma NCT04899570 | Peking Union Medical College Hospital | Phase 2 |
| Active Not Recruiting | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lympho NCT03038672 | National Cancer Institute (NCI) | Phase 2 |
| Suspended | Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma NCT03704714 | Northwestern University | Phase 1 / Phase 2 |